These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33787823)

  • 1. Simultaneous or Rapid Sequence Initiation of Quadruple Medical Therapy for Heart Failure-Optimizing Therapy With the Need for Speed.
    Greene SJ; Butler J; Fonarow GC
    JAMA Cardiol; 2021 Jul; 6(7):743-744. PubMed ID: 33787823
    [No Abstract]   [Full Text] [Related]  

  • 2. Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure.
    Greene SJ; Ayodele I; Pierce JB; Khan MS; Lewsey SC; Yancy CW; Alhanti B; Van Spall HGC; Allen LA; Fonarow GC
    JACC Heart Fail; 2024 Aug; 12(8):1365-1377. PubMed ID: 38597866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full decongestion in acute heart failure therapy.
    Buttar C; Alai H; Matanes FN; Cassidy MM; Stencel J; Le Jemtel TH
    Am J Med Sci; 2024 Sep; 368(3):182-189. PubMed ID: 38880301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Care for Heart Failure With Reduced Ejection Fraction-A Potential Polypill-Based Strategy.
    Agarwal A; Yancy CW; Huffman MD
    JAMA; 2020 Dec; 324(22):2259-2260. PubMed ID: 33211084
    [No Abstract]   [Full Text] [Related]  

  • 5. How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction?: A Redefinition of Evidence-Based Medicine.
    McMurray JJV; Packer M
    Circulation; 2021 Mar; 143(9):875-877. PubMed ID: 33378214
    [No Abstract]   [Full Text] [Related]  

  • 6. Strategy for an early simultaneous introduction of four-pillars of heart failure therapy: results from a single center experience.
    Severino P; D'Amato A; Prosperi S; Mariani MV; Myftari V; Labbro Francia A; Cestiè C; Tomarelli E; Manzi G; Birtolo LI; Marek-Iannucci S; Maestrini V; Mancone M; Badagliacca R; Fedele F; Vizza CD
    Am J Cardiovasc Drugs; 2024 Sep; 24(5):663-671. PubMed ID: 38909334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Centered Heart Failure Therapy.
    Samson R; Ennezat PV; Jemtel THL
    Am J Med; 2024 Jan; 137(1):23-29. PubMed ID: 37838238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guideline-Directed Medical Therapy Clinics: A Call to Action for the Heart Failure Team.
    O'Connor CM
    JACC Heart Fail; 2019 May; 7(5):442-443. PubMed ID: 31047024
    [No Abstract]   [Full Text] [Related]  

  • 9. Embracing an era of targeted combination therapy for heart failure with preserved ejection fraction.
    Shoji S; Greene SJ; Mentz RJ
    Heart Fail Rev; 2024 Nov; 29(6):1235-1238. PubMed ID: 39187605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
    MMW Fortschr Med; 2004 Oct; 146(43):58-9. PubMed ID: 15559524
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug treatment of chronic heart failure].
    Böhm M; Werner N; Kindermann M
    Clin Res Cardiol; 2006; 95 Suppl 4():36-54; quiz 55-6. PubMed ID: 16598606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
    Güder G; Störk S; Gelbrich G; Brenner S; Deubner N; Morbach C; Wallenborn J; Berliner D; Ertl G; Angermann CE
    Eur J Heart Fail; 2015 Apr; 17(4):442-52. PubMed ID: 25727879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity-Related Heart Failure With a Preserved Ejection Fraction: The Mechanistic Rationale for Combining Inhibitors of Aldosterone, Neprilysin, and Sodium-Glucose Cotransporter-2.
    Packer M; Kitzman DW
    JACC Heart Fail; 2018 Aug; 6(8):633-639. PubMed ID: 29525327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should we revise our approach to 'optimal medical therapy'? The case of chronic heart failure.
    Tavazzi L; Maggioni AP; Borer JS
    Eur Heart J; 2013 Sep; 34(36):2792-4. PubMed ID: 23892200
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic heart failure: progress in diagnosis and treatment. Topics: III. Progress in prevention, control and treatment: 3. Evidence-based pharmacologic therapy for chronic heart failure].
    Kinugawa K
    Nihon Naika Gakkai Zasshi; 2012 Feb; 101(2):379-86. PubMed ID: 22523807
    [No Abstract]   [Full Text] [Related]  

  • 16. A Stepwise Approach to the Management of Heart Failure and its Comorbidities.
    Rogers FJ; Saghir Z
    J Am Osteopath Assoc; 2020 Feb; 120(2):90-99. PubMed ID: 31985768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure].
    Mundhenke M
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2297-8; author reply 2298. PubMed ID: 17036279
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
    Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
    Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ivabradine and outcomes in chronic heart failure.
    Gupta A; Sharma YP
    Lancet; 2010 Dec; 376(9758):2069; author reply 2069-70. PubMed ID: 21168044
    [No Abstract]   [Full Text] [Related]  

  • 20. New drugs: big changes in conservative heart failure therapy?
    Berliner D; Bauersachs J
    Eur J Cardiothorac Surg; 2019 Jun; 55(Suppl 1):i3-i10. PubMed ID: 31106335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.